Search

Your search keyword '"Padalko, Elizaveta"' showing total 445 results

Search Constraints

Start Over You searched for: Author "Padalko, Elizaveta" Remove constraint Author: "Padalko, Elizaveta"
445 results on '"Padalko, Elizaveta"'

Search Results

3. Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial

4. Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance

8. Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study).

9. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme

12. SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, Belgium.

13. Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination.

15. Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022

18. Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients

27. Does screening for Neisseria gonorrhoeae and Chlamydia trachomatis affect the incidence of these infections in men who have sex with men taking HIV pre-exposure prophylaxis (PrEP) ? Results from a randomized, multicentre controlled trial (the Gonoscreen study)

29. Effect of screening for Neisseria gonorrhoeaeand Chlamydia trachomatison incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial

32. Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

33. Estimation of the real magnitude of antimicrobial resistance of Mycoplasma genitalium in Belgium by implementing a prospective surveillance programme.

34. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples

35. The prognosis of hepatitis delta infections in Belgium is poor and determined by the hepatitis delta viremia

36. Preanalytical variables influencing the interpretation and reporting of biological tests on blood samples of living and deceased donors for human body materials

39. SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study – the BELCOMID study

40. Human Papillomavirus Negative High Grade Cervical Lesions and Cancers: Suggested Guidance for Hpv Testing Quality Assurance

41. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex II HPV28 assays for high-risk HPV detection and genotyping in mocked self-samples

44. Risk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection

48. Delayed presentations of severe combined immunodeficiency during the SARS‑CoV‑2 pandemic

49. Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

50. Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients

Catalog

Books, media, physical & digital resources